Impact Factor 2022
The Impact Factor 2022 for the UiM/EJU is 3.4
UiM/EJU subscribers
are now provided with
a mobile digital issue
of their journal.
The eRef app enables
you to comfortably
read the latest journal issues on your tablet.
Find out more about the eRef app here
Use UiM/EJU offline • optimal reading experience • scalable font size • one click to download UiM/EJU
Ultrasound International Open
New open-access journal!
For author instructions and further information about publishing in UIO, visit www.thieme.com/uio
EFSUMB on FACEBOOK
EFSUMB NEWS
|
More information on all EUROSON Schools can be found on www.efsumb.org >>
European Journal of Ultrasound 03-2024
Prevalence of sonographic signs in women with uterine sarcoma: a systematic review and meta-analysis
Raffone A, Raimodno D, Neola D et al.
To assess the prevalence of sonographic signs in women with uterine sarcoma. A systematic review and meta-analysis were performed. Five electronic databases were searched from inception to June 2022 for all studies allowing calculation of the prevalence of sonographic signs in women with uterine sarcoma.
Gitto S, Albano D, Serpi F et al.
The purpose of this study is to investigate the role of ultrasound (US) in the evaluation of intrinsic and extrinsic ligaments of the wrist with magnetic resonance arthrography (MRA) as the reference standard. This prospective study included patients referred for MRA after wrist trauma. US examination was performed just before MRA. On the dorsal and palmar sides of the wrist, the intrinsic interosseus and midcarpal, extrinsic, and collateral ligaments were evaluated. MRA was performed on a 1.5-T unit. In the first 20 patients included, ligament thickness was independently assessed using US and MRA and thickness reproducibility was calculated. Ligament integrity was evaluated in all patients.
Xholli A, Londero AP, Cavalli E et al.
This study aimed to evaluate elastography features of deep infiltrating endometriosis (DIE), and to define whether this technique may discriminate lesions from surrounding non-endometriotic tissue. This was an exploratory observational study on women affected by DIE treated in a third-level academic hospital gynaecology outpatient facility between 2020 and 2021.